Annual Data
Quarterly Data
Johnson & Johnson (NYSE:JNJ), Common-Size Assets (Q)
Merck & Co. Inc. (NYSE:MRK), Common-Size Assets (Q)
Pfizer Inc. (NYSE:PFE), Common-Size Assets (Q)
Abbott Laboratories (NYSE:ABT), Common-Size Assets (Q)
AbbVie Inc. (NYSE:ABBV), Common-Size Assets (Q)
Eli Lilly & Co. (NYSE:LLY), Common-Size Assets (Q)
Amgen Inc. (NASDAQ:AMGN), Common-Size Assets (Q)
Bristol-Myers Squibb Co. (NYSE:BMY), Common-Size Assets (Q)
Gilead Sciences Inc. (NASDAQ:GILD), Common-Size Assets (Q)
Zoetis Inc. (NYSE:ZTS), Common-Size Assets (Q)
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Common-Size Assets (Q)
Biogen Inc. (NASDAQ:BIIB), Common-Size Assets (Q)
Illumina Inc. (NASDAQ:ILMN), Common-Size Assets (Q)
Regeneron Pharmaceuticals Inc., common-size consolidated balance sheet: assets (quarterly data)
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015
Mar 31, 2015
Cash and cash equivalents
13.81% 14.01% 10.93% 9.93% 7.94% 13.29% 12.51% 10.07% 9.22% 10.88% 9.27% 9.10% 9.18% 10.38% 7.67% 13.48% 10.42% 10.23% 14.42% 12.63% 8.63% 12.10%
Marketable securities
7.98% 11.39% 10.78% 10.71% 12.33% 11.85% 11.44% 10.22% 7.69% 6.46% 6.81% 6.74% 6.46% 6.34% 7.22% 7.15% 6.42% 4.15% 4.21% 4.65% 4.72% 5.58%
Accounts receivable, trade, net
13.80% 13.09% 14.18% 14.55% 14.58% 13.45% 14.69% 15.42% 15.42% 16.34% 17.56% 17.61% 17.52% 17.14% 19.26% 19.51% 23.08% 24.57% 20.55% 21.00% 23.67% 24.20%
Accounts receivable, Sanofi
2.70% 2.97% 1.76% 2.48% 1.91% 2.24% 1.93% 2.49% 2.44% 1.80% 2.21% 2.50% 2.73% 2.74% 1.33% 1.82% 2.23% 2.94% 2.73% 3.84% 4.37% 3.80%
Accounts receivable, other
2.99% 2.55% 2.10% 2.06% 2.15% 2.25% 2.50% 2.48% 2.63% 2.59% 2.76% 2.54% 2.51% 2.50% 2.51% 2.75% 2.93% 4.08% 2.89% 2.93% 2.78% 3.88%
Inventories
11.37% 9.40% 9.56% 9.64% 10.00% 9.40% 9.81% 9.62% 9.33% 8.75% 8.29% 7.37% 6.84% 5.97% 5.73% 5.06% 5.09% 5.14% 4.25% 3.68% 3.78% 3.19%
Deferred tax assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.17% 1.54% 1.48%
Prepaid expenses and other current assets
1.83% 1.44% 2.61% 1.63% 1.58% 1.42% 2.07% 2.64% 1.64% 1.66% 2.57% 1.65% 2.38% 1.87% 1.87% 1.52% 1.55% 1.96% 2.91% 1.73% 0.95% 0.81%
Current assets
54.48%
54.86%
51.94%
51.00%
50.49%
53.90%
54.95%
52.93%
48.38%
48.49%
49.46%
47.53%
47.62%
46.94%
45.60%
51.28%
51.72%
53.07%
51.97%
51.62%
50.44%
55.04%
Marketable securities
17.93% 20.54% 22.00% 22.33% 21.90% 18.20% 14.96% 17.34% 20.55% 19.44% 16.96% 15.25% 13.13% 12.38% 12.39% 11.39% 9.51% 9.40% 11.27% 13.15% 13.02% 11.51%
Property, plant, and equipment, net
21.01% 18.69% 19.52% 19.88% 20.32% 20.33% 21.95% 23.36% 24.73% 25.55% 26.91% 26.14% 27.90% 29.13% 29.88% 27.42% 28.57% 28.22% 28.42% 28.46% 29.29% 26.45%
Deferred tax assets
5.36% 4.89% 5.57% 5.80% 6.24% 6.45% 7.06% 5.21% 5.48% 5.68% 5.78% 10.65% 10.89% 11.08% 11.83% 9.60% 10.09% 9.21% 8.24% 6.68% 7.15% 6.89%
Other noncurrent assets
1.22% 1.02% 0.98% 0.99% 1.06% 1.12% 1.09% 1.16% 0.86% 0.84% 0.89% 0.42% 0.46% 0.47% 0.29% 0.30% 0.11% 0.10% 0.10% 0.09% 0.09% 0.11%
Noncurrent assets
45.52%
45.14%
48.06%
49.00%
49.51%
46.10%
45.05%
47.07%
51.62%
51.51%
50.54%
52.47%
52.38%
53.06%
54.40%
48.72%
48.28%
46.93%
48.03%
48.38%
49.56%
44.96%
Total assets
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
Based on:
10-Q (filing date: 2020-08-05) 10-Q (filing date: 2020-05-05) 10-K (filing date: 2020-02-07) 10-Q (filing date: 2019-11-05) 10-Q (filing date: 2019-08-06) 10-Q (filing date: 2019-05-07) 10-K (filing date: 2019-02-07) 10-Q (filing date: 2018-11-06) 10-Q (filing date: 2018-08-02) 10-Q (filing date: 2018-05-03) 10-K (filing date: 2018-02-08) 10-Q (filing date: 2017-11-08) 10-Q (filing date: 2017-08-03) 10-Q (filing date: 2017-05-04) 10-K (filing date: 2017-02-09) 10-Q (filing date: 2016-11-04) 10-Q (filing date: 2016-08-04) 10-Q (filing date: 2016-05-05) 10-K (filing date: 2016-02-11) 10-Q (filing date: 2015-11-04) 10-Q (filing date: 2015-08-04) 10-Q (filing date: 2015-05-07)
Balance sheet item
Description
The company
Current assets
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Regeneron Pharmaceuticals Inc.’s current assets as a percentage of total assets increased from Q4 2019 to Q1 2020 but then slightly decreased from Q1 2020 to Q2 2020.
Property, plant, and equipment, net
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Regeneron Pharmaceuticals Inc.’s property, plant, and equipment, net as a percentage of total assets decreased from Q4 2019 to Q1 2020 but then increased from Q1 2020 to Q2 2020 exceeding Q4 2019 level.
Noncurrent assets
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Regeneron Pharmaceuticals Inc.’s noncurrent assets as a percentage of total assets decreased from Q4 2019 to Q1 2020 but then slightly increased from Q1 2020 to Q2 2020.
